Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Roxgold Inc. T.ROXG

Metals & Mining Industrial Metals & Minerals
Roxgold Inc is a Canadian gold mining company. It is engaged in acquiring and exploring mineral properties. The company has two reportable segments; Mining operations and Exploration and evaluation of mineral properties, located in Burkina Faso. Its key asset is the Yaramoko Gold Mine, located in the Hounde greenstone belt of Burkina Faso, West Africa, and Seguela Gold Project located in Cote d... see more

Recent & Breaking News (TSX:ROXG)

FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation

Business Wire August 7, 2017

FDA Grants Genentech’s Alecensa Priority Review for Initial Treatment of People with ALK-Positive Lung Cancer

Business Wire August 3, 2017

Roche to showcase power of connected lab at AACC 2017 Clinical Lab Expo

PR Newswire July 31, 2017

Positive Phase III Results of Genentech’s Actemra (Tocilizumab) for the Treatment of Giant Cell Arteritis Published in New England Journal of Medicine

Business Wire July 26, 2017

Accenture to Transform Diabetic Patient Care Using Data-driven Analytics Platform

Business Wire July 26, 2017

Roche launches the AVENIO Millisect System for precise and efficient dissection of tissue biopsies

PR Newswire July 26, 2017

Roche signs collaboration agreement to create core data platform for its digital diabetes ecosystem

PR Newswire Europe Non Regulatory July 26, 2017

Roche gains CE label expansion for companion diagnostic to identify ALK-positive non-small cell lung cancer patients

PR Newswire Europe Non Regulatory July 25, 2017

Roxgold Produces 27,970 Ounces of Gold at Yaramoko in Q2 and Remains on Track to Achieve Upper End of Annual Production Guidance

Canada NewsWire July 25, 2017

Roche expands Global Access Program to include the first fully automated CE marked nucleic acid HIV-1/HIV-2 qualitative diagnostic test

PR Newswire Europe Non Regulatory July 25, 2017

Roxgold Provides Notice of Release Date for its 2017 Second Quarter Financial Results and Conference Call Details

PR Newswire July 20, 2017

Roxgold Announces Significant Grade Increases in Updated Bagassi South Mineral Resource Estimate

Canada NewsWire July 19, 2017

Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Business Wire July 10, 2017

Roche launches the first fully automated CE marked HIV-1/HIV-2 qualitative diagnostic test on cobas® 6800/8800 Systems

PR Newswire Europe Non Regulatory July 4, 2017

Roxgold Announces Voting Results of Annual and Special Meeting

Canada NewsWire June 28, 2017

Roche expands Harmony® Prenatal Test to include 22q11.2 deletion testing

PR Newswire Europe Non Regulatory June 28, 2017

Roxgold Commences Drill Program Targeting New Geophysical Anomalies Along Bagassi Corridor

PR Newswire June 28, 2017

Genentech’s Emicizumab Showed Positive Results in Phase III Studies (HAVEN 1 and HAVEN 2) in Hemophilia A With Inhibitors

Business Wire June 26, 2017

Roche receives FDA approval for fourth-generation HIV combination antigen-antibody assay --allowing detection of infection with high sensitivity and specificity

PR Newswire June 23, 2017

New Data at EAN Show Genentech’s Ocrevus (Ocrelizumab) Significantly Reduced Multiple Measures of Disease Progression in Relapsing and Primary Progressive Multiple Sclerosis

Business Wire June 23, 2017